Potential of (18)F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer

PURPOSE: We investigated the metabolic response of lung cancer to radiotherapy or chemoradiotherapy by (18)F-FDG PET and its utility in guiding timely supplementary therapy. METHODS: Glucose metabolic rate (MRglc) was measured in primary lung cancers during the 3 weeks before, and 10–12 days (S2), 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Noah C., Chun, Tristen T., Niemierko, Andrzej, Ancukiewicz, Marek, Fidias, Panos M., Kradin, Richard L., Mathisen, Douglas J., Lynch, Thomas J., Fischman, Alan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644202/
https://www.ncbi.nlm.nih.gov/pubmed/23400506
http://dx.doi.org/10.1007/s00259-013-2348-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644202/
https://www.ncbi.nlm.nih.gov/pubmed/23400506
http://dx.doi.org/10.1007/s00259-013-2348-4

Ejemplares similares